^Back To Top

foto1 foto2 foto3 foto4 foto5


Impact Factor : 8.003 ...... IJAHM Latest Issue IJAHM have published its latest issue Vol. 15 Issue 01, Jan.-Feb. 2025 published IJAHM Call For Paper invites paper from various Ayurveda & herbal Medicine for Volume 15 Issue 01 Jan.-Feb..-2025

  Priyanka Rani1 , Shruti Vaishnava2 , Gunjan Sharma3

1Assistant Professor, P.G. Department of Shalakya Tantra, Rishikul Campus, Haridwar, Uttarakhand Ayurved University, Uttarakhand, India.

2P.G. Scholar, P.G. Department of Shalakya Tantra, Rishikul Campus, Haridwar, Uttarakhand Ayurved University, Uttarakhand, India.

3Professor and H.O.D., P.G. Shalakya Tantra, Rishikul Campus, Haridwar, Uttarakhand Ayurved University, Uttarakhand, India.

http://dx.doi.org/10.47191/ijahm/v14i6.08

ABSTRACT: Anjana is an Ayurvedic medicinal formulation that is used in “Sampakvadosha” condition.1 Anjana also known as collyrium is a topical application of drug in the form of smooth paste into the conjunctival fornices with an applicator. Although Anjanas are meant for eye diseases yet it has wide application in systemic diseases too. Anjana is used when the acute inflammatory features subside and the clinical feature of each dosha become manifested and localized in the eye. Anjana preparation are compound drugs prepared out of metal, minerals, herbs and animal materials. Generally Arsenic, Antimony, Lead and Tin compounds are frequently prescribed. Dosage and duration are aptly prescribed to avoid noncompliance. Disposal of the drug is very minimal so the tissue contact time is more; absorption is maximum thus bioavailability is naturally more. Probably, it acts as subconjunctival injection, permeability is also possible through the sclera and enters into the systemic circulation and may act on posterior segmental disorders of the eye. The metals in Anjana preparation having larger molecular weight do not cross the blood aqueous barrier when administered systematically. The treatment plan of Praklinna Vartma mentioned in Sushruta Samhita includes Yoganjana along with other ocular therapeutic procedures. Yoganjana is an Ayurvedic formulation mentioned in Sushruta Samhita used to treat Vartmagata disease namely Praklinna Vartma. Keeping all the points, this study has been undertaken with the aim to modify Yoganjana in ointment form. The Anjana was prepared through “Ghana Satva Kalpana”.

KEYWORD :  Yoganjana, Analytical Study, Praklinna Vartma, Seborrhoeic Blepharitis.

REFERENCES:

1. Sharangdhara Samhita, Uttara khanda, 13/62. Deepika Commentary, Chaukhambha Sanskrit Sansthan, Varanasi; Reprint ,2023, P 283.

2. Sushruta Samhita, Uttartantra Ayurveda-Tattva-Sandipika, Hindi Vyakhya, Edited by Kaviraj Ambikadutta Shastri; Chaukhambha Sanskrit Sansthan, Varanasi, Edition: Reprint,2018, Ch 3 / 21, P 23.

3. Sushruta Samhita, Uttartantra Ayurveda-Tattva-Sandipika, Hindi Vyakhya, Edited by Kaviraj Ambikadutta Shastri; Chaukhambha Sanskrit Sansthan, Varanasi, Edition: Reprint,2018, Ch12/47 P 63.

4. Sushruta Samhita, Uttartantra Ayurveda-Tattva-Sandipika, Hindi Vyakhya, Edited by Kaviraj Ambikadutta Shastri; Chaukhambha Sanskrit Sansthan, Varanasi, Edition: Reprint,2018, Ch11/16 P 58.

5. Vagabhatta, Sutrasthana 2/5 Ashtang Hridayam, Srimadvagbhattavirachitam, Vidyotini Commentary, By Kaviraj Atridev Gupt, P 22.

6. Sushruta Samhita, Uttartantra Ayurveda-Tattva-Sandipika, Hindi Vyakhya, Edited by Kaviraj Ambikadutta Shastri; Chaukhambha Sanskrit Sansthan, Varanasi, Edition: Reprint,2018, Ch18/4 P 93.

7. Sushruta Samhita, Uttartantra Ayurveda-Tattva-Sandipika, Hindi Vyakhya, Edited by Kaviraj Ambikadutta Shastri; Chaukhambha Sanskrit Sansthan, Varanasi, Edition: Reprint, 2018 , 24/18, P 132.

8. Sushruta Samhita, Uttartantra Ayurveda-Tattva-Sandipika, Hindi Vyakhya, Edited by Kaviraj Ambikadutta Shastri; Chaukhambha Sanskrit Sansthan, Varanasi, Edition: Reprint, 2018 , 24/19, P 132.

9. Anonymous, The Ayurvedic Pharmacopia of India. Government of India. Ministry of Health and Family Welfare. Department of Indian Systems of Medicine and Homeopathy.

IJAHM Content

IJAHM Menu

Download

Crossref - DOI

DOI : 10.47191/ijahm

Impact Factor 2024: 8.003

2023: 7.734

2022: 6.704

2021: 6.643

2019: 5.692

2018: 5.485

2017: 4.965

2016: 4.415 

Facebook

Who's Online

We have 22 guests and no members online

index

ind.pngkindex.jpglogo_2.pngnewj.pngtop_up.jpguindex.jpgule.jpg
 Copyright © 2025 IJAHM  Rights Reserved.